Fact sheet: AXA Framlington Biotech

Fund information

Fund name
AXA Framlington Biotech Z Acc
Fund company manager
AXA IM UK
Fund type
UKA
Fund manager(s)
Linden Thomson
since 05/07/2012
Fund objective
The aim of this Fund is to provide long-term capital growth.
Benchmark
NASDAQ Biotechnology
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

17.51 %

1 Year rank in sector

12/109

Sector

UT Specialist

Yield
-
Fund size

£ 546.8 m

FE Risk score

220

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    87.07%
  • UK
    5.12%
  • France
    2.93%
  • Belgium
    2.03%
  • Sweden
    0.96%
  • Biotechnology/Medical
    79.56%
  • Pharmaceuticals
    14.54%
  • Electronic & Electrical Equipment
    2.57%
  • Technology
    1.96%
  • Health Care
    1.05%
  • US Equities
    87.07%
  • UK Equities
    5.12%
  • French Equities
    2.93%
  • Belgian Equities
    2.03%
  • Swedish Equities
    0.96%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund3.33 %14.47 %17.51 %54.67 %184.29 %
Sector1.99 %4.61 %6.91 %28.34 %33.51 %
Rank within sector28 / 1136 / 11312 / 10921 / 1041 / 89
Quartile th1 st1 st1 st1 st1 st

Calendar performance

YTD-20172016201520142013
Fund17.55 %-4.95 %12.29 %46.68 %65.24 %
Sector7.46 %22.72 %-4.47 %1.15 %4.5 %
Rank within sector12 / 109108 / 1084 / 1044 / 1001 / 90
Quartile th1 st4 th1 st1 st1 st

Risk statistics

Alpha9.1
Beta0.79
Sharpe0.38
Volatility24.07
Tracking error22.89
Information ratio0.2
R-Squared0.1

Price movement

52 week high349.3
52 week low261
Current bid price0
Current offer price0
Current mid price340.9

Holdings by region

  • 87.07% USA
  • 5.12% UK
  • 2.93% France
  • 2.03% Belgium
  • 0.96% Sweden
  • 0.69% Netherlands
  • 0.46% Canada
  • 0.36% Germany
  • 0.32% Money Market
  • 0.06% Switzerland

Holdings by sector

  • 79.56% Biotechnology/Medical
  • 14.54% Pharmaceuticals
  • 2.57% Electronic & Electrical Equipment
  • 1.96% Technology
  • 1.05% Health Care
  • 0.32% Money Market

Holdings by asset type

  • 87.07% US Equities
  • 5.12% UK Equities
  • 2.93% French Equities
  • 2.03% Belgian Equities
  • 0.96% Swedish Equities
  • 0.69% Dutch Equities
  • 0.46% Canadian Equities
  • 0.36% German Equities
  • 0.32% Money Market
  • 0.06% Swiss Equities

Individual holdings

  • 10.33% GILEAD SCIENCES INC
  • 10.26% BIOGEN INC
  • 7.68% CELGENE CORP
  • 6.52% REGENERON PHARMACEUTICALS INC
  • 5.91% ALEXION PHARMACEUTICALS INC
  • 4.48% AMGEN INC
  • 4.48% VERTEX PHARMACEUTICAL
  • 3.52% BIOMARIN PHARMACEUTICAL
  • 2.8% INCYTE CORP
  • 2.71% SHIRE PLC